Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024
August 15, 2024 16:15 ET
|
Alvotech
Record Total Revenues of $236 million for the first six months of 2024, an over ten-fold increase compared to same period in 2023 Product revenues for the first six months were $66...
European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
August 15, 2024 04:30 ET
|
Alvotech
The approvals process is anticipated to be completed in the third quarter of 2025 REYKJAVIK, Iceland and LONDON, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company...
Alvotech mun birta uppgjör fyrri árshelmings 2024 fimmtudaginn 15. ágúst nk. og streyma uppgjörsfundi föstudaginn 16. ágúst nk. kl. 12:00 að íslenskum tíma
August 01, 2024 16:01 ET
|
Alvotech
Alvotech (NASDAQ: ALVO) mun senda út tilkynningu með uppgjöri fyrir fyrri helming ársins 2024 eftir lokun markaða í Bandaríkjunum, fimmtudaginn 15. ágúst nk. Þá mun Alvotech halda kynningarfund fyrir...
Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET
August 01, 2024 16:01 ET
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, will release financial results for first half of the...
Plant Advanced Techonolgies : Hausse du Chiffre d’Affaires Combiné au 30 juin 2024
July 22, 2024 12:36 ET
|
Plant Advanced Technologies
Vandœuvre-lès-Nancy, le 22 juillet 2024 - 18 : 30 (CET) Communiqué de pressePour diffusion immédiate Hausse du Chiffre d’Affaires Combiné au 30 juin 2024 Chiffre d’affaires semestriel non audité du...
Amendment of Disclosures in Past Management Information Circulars
July 16, 2024 18:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) -- As a result of a review by the British Columbia Securities Commission, BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE:...
Alvotech Announces Closing of Private Debt Financing
July 11, 2024 04:45 ET
|
Alvotech
REYKJAVIK, Iceland, July 11, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...
BetterLife Announces Closing of a Private Placement
July 02, 2024 18:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, July 02, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Alvotech Issues New Shares to Holders of Convertible Bonds
July 01, 2024 17:35 ET
|
Alvotech
REYKJAVIK, Iceland, July 01, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...
BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
June 26, 2024 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 26, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...